- Review Article
- Other
- Cost-effectiveness of newborn screening for severe combined immunodeficiency: a systematic review
-
Rezwanul Rana, Syed Afroz Keramat, Moin Ahmed
-
Clin Exp Pediatr. 2025;68(9):628-640. Published online April 16, 2025
-
|
Universal newborn screening for severe combined immunodeficiency (SCID) demonstrates robust cost-effectiveness across diverse high-income healthcare systems, both from healthcare and societal standpoints. Early detection yields substantial savings. While uncertainties persist, impacting precise cost-effectiveness, the overall finding is positive. Future research must prioritize enhanced data collection and statistical rigor to refine our understanding of SCID's economic impact within the Australian context. |
-
-
|